Ingrid Hedenfalk相关文献与解析，生知库 | 链接生命科学的每一步

Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis

代谢

肿瘤

乳腺癌

发表日期：2024

文献求助收藏

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells

乳腺癌相关 CD169+ 巨噬细胞具有广泛的免疫抑制功能，但可增强活化 B 细胞的抗体分泌

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2023.1180209

Frida Björk Gunnarsdottir, Oscar Briem, Aida Yifter Lindgren, Eva Källberg, Cajsa Andersen, Robert Grenthe, Cassandra Rosenqvist, Camilla Rydberg Millrud, Mika Wallgren, Hannah Viklund, Daniel Bexell, Martin E Johansson, Ingrid Hedenfalk, Catharina Hagerling, Karin Leandersson

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer

预测顺铂敏感性的深度表格数据学习模型可识别癌症中的 BCL2L1 依赖性

期刊:Computational and Structural Biotechnology Journal

影响因子:4.4

doi:10.1016/j.csbj.2023.01.020

Ahmad Nasimian, Mehreen Ahmed, Ingrid Hedenfalk, Julhash U Kazi

肿瘤

发表日期：2023

文献求助收藏

CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer

乳腺原发性肿瘤中的 CD169+ 巨噬细胞与三级淋巴结构、Treg 以及晚期乳腺癌患者的预后较差相关

期刊:Cancers

影响因子:

doi:10.3390/cancers15041262

Oscar Briem, Eva Källberg, Siker Kimbung, Srinivas Veerla, Jenny Stenström, Thomas Hatschek, Catharina Hagerling, Ingrid Hedenfalk, Karin Leandersson

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer

致癌翻译指导剪接体动力学，揭示 SF3A3 在乳腺癌中的重要作用

期刊:Molecular Cell

影响因子:14.5

doi:10.1016/j.molcel.2021.01.034

Maciej Cieśla, Phuong Cao Thi Ngoc, Eugenia Cordero, Álvaro Sejas Martinez, Mikkel Morsing, Sowndarya Muthukumar, Giulia Beneventi, Magdalena Madej, Roberto Munita, Terese Jönsson, Kristina Lövgren, Anna Ebbesson, Björn Nodin, Ingrid Hedenfalk, Karin Jirström, Johan Vallon-Christersson, Gabriella Ho

信号转导

肿瘤

乳腺癌

Translational Control

发表日期：2021

文献求助收藏

Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression

转移性乳腺癌中的调节性T淋巴细胞浸润——随肿瘤进展而变化的独立预后因素

期刊:Breast Cancer Research

影响因子:6.1

doi:10.1186/s13058-021-01403-0

Jenny Stenström, Ingrid Hedenfalk, Catharina Hagerling

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

氟维司群治疗耐药的不同机制决定了转移性乳腺癌中 ER 独立性水平和对 CDK 抑制剂的选择性反应

期刊:Breast Cancer Research

影响因子:6.1

doi:10.1186/s13058-021-01402-1

Kamila Kaminska #, Nina Akrap #, Johan Staaf, Carla L Alves, Anna Ehinger, Anna Ebbesson, Ingrid Hedenfalk, Lukas Beumers, Srinivas Veerla, Katja Harbst, Sidse Ehmsen, Signe Borgquist, Åke Borg, Alejandro Pérez-Fidalgo, Henrik J Ditzel, Ana Bosch #, Gabriella Honeth #

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer

MET 表达和癌症干细胞网络影响高级别浆液性卵巢癌的结果

期刊:Genes

影响因子:

doi:10.3390/genes12050742

Maria Bååth, Jenny-Maria Jönsson, Sofia Westbom Fremer, Laura Martín de la Fuente, Lena Tran, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Gabriella Honeth, Ingrid Hedenfalk

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

PD-1/PD-L1 表达和肿瘤浸润淋巴细胞对晚期高级别浆液性卵巢癌具有预后良好作用

期刊:Virchows Archiv

影响因子:3.4

doi:10.1007/s00428-020-02751-6

Laura Martin de la Fuente, Sofia Westbom-Fremer, Nicolai Skovbjerg Arildsen, Linda Hartman, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Ingrid Hedenfalk

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery

对于减瘤手术后残留疾病的晚期高级别浆液性卵巢癌患者，SOX2 是复发和死亡的有希望的预测因子

期刊:Molecular and Cellular Oncology

影响因子:2.6

doi:10.1080/23723556.2020.1805094

Maria Bååth, Sofia Westbom-Fremer, Laura Martin de la Fuente, Anna Ebbesson, Juliette Davis, Susanne Malander, Anna Måsbäck, Päivi Kannisto, Ingrid Hedenfalk

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

纵向分子分析阐明乳腺癌的免疫代谢动态

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells

乳腺癌相关 CD169+ 巨噬细胞具有广泛的免疫抑制功能，但可增强活化 B 细胞的抗体分泌

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer

预测顺铂敏感性的深度表格数据学习模型可识别癌症中的 BCL2L1 依赖性

CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer

乳腺原发性肿瘤中的 CD169+ 巨噬细胞与三级淋巴结构、Treg 以及晚期乳腺癌患者的预后较差相关

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer

致癌翻译指导剪接体动力学，揭示 SF3A3 在乳腺癌中的重要作用

Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression

转移性乳腺癌中的调节性T淋巴细胞浸润——随肿瘤进展而变化的独立预后因素

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

氟维司群治疗耐药的不同机制决定了转移性乳腺癌中 ER 独立性水平和对 CDK 抑制剂的选择性反应

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer

MET 表达和癌症干细胞网络影响高级别浆液性卵巢癌的结果

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

PD-1/PD-L1 表达和肿瘤浸润淋巴细胞对晚期高级别浆液性卵巢癌具有预后良好作用

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery

对于减瘤手术后残留疾病的晚期高级别浆液性卵巢癌患者，SOX2 是复发和死亡的有希望的预测因子